Long-term results after the Ross procedure with the decellularized AutoTissue Matrix P® bioprosthesis used for pulmonary valve replacement
Author(s) -
Torsten Christ,
Alexandru Claudiu Paun,
Herko Grubitzsch,
Sebastian Holinski,
Volkmar Falk,
Simon Dushe
Publication year - 2018
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezy377
Subject(s) - medicine , prosthesis , decellularization , surgery , aortic valve , aortic valve replacement , ross procedure , cardiology , biomedical engineering , stenosis , tissue engineering
Since 1967, the Ross procedure has been performed to treat aortic valve disease using homografts for pulmonary valve replacement. The decellularized Matrix P® prosthesis was developed to overcome (some) limitations of homografts. Until now, the long-term outcome data have been unavailable.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom